event,time
57 years old , 0
male , 0
lepromatous leprosy , -60
skin biopsy , -60
treatment with rifampicin/clofazimine/dapsone , -60
admitted to the hospital , 0
abdominal distension , 0
constipation , 0
vomiting , 0
10-kg weight loss , 0
peripheral lymphadenopathy , 0
distended abdomen , 0
positive shifting dullness , 0
computed tomography scan of abdomen , 0
mural thickening of terminal ileum , 0
enlarged mesenteric lymph nodes , 0
mesenteric fat stranding , 0
intra-abdominal free fluid , 0
abdominal paracentesis , 0
atypically large lymphocytes , 0
flow cytometry , 0
abnormal CD4/CD8 double-negative T-cell population , 0
cervical lymph node biopsy , 0
high-grade peripheral T-cell lymphoma , 0
bone marrow examination , 0
no involvement of T-cell NHL , 0
stage IV lymphoma , 0
dexamethasone , 0
tumor-lysis syndrome precautions , 0
deteriorated clinically , 24
transferred to medical ICU , 24
severe sepsis , 24
antibiotics , 24
antifungals , 24
ICU care , 24-168
recovered , 168
transferred to national cancer center , 168
EPOCH chemotherapy protocol , 168
CNS prophylaxis , 168
intrathecal methotrexate , 168
febrile neutropenia episodes , 336
recurrent bacteremia , 336
generalized weakness , 336
no sensory changes , 336
no clear fatigability , 336
decreased power in proximal and distal muscles , 336
normal distal latencies , 336
normal compound muscle action potential , 336
normal conduction velocities , 336
normal F waves , 336
normal sensory nerve studies , 336
needle electromyogram , 336
poor recruitment effects , 336
repetitive nerve stimulation , 336
significant incremental response , 336
presynaptic neuromuscular junction disorder , 336
LEMS , 336
intravenous immunoglobulins , 336
significant improvement of motor function , 360
ambulate , 360
planned for consolidation by autologous bone marrow transplant , 360
recurrent bacteremia and sepsis , 720
re-admitted to medical ICU , 720
severe sepsis and multiorgan failure , 720
passed away , 1440
